Hemophilia A differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
[[Hemophilia A]] must be differentiated from other diseases that cause abnormal or excessive bleeding.<ref> Konkle BA, Josephson NC, Nakaya Fletcher S. Hemophilia A. 2000 Sep 21 [Updated 2014 Jun 5]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www-ncbi-nlm-nih-gov.laneproxy.stanford.edu/books/NBK1404/ </ref>
[[Hemophilia A]] must be differentiated from other diseases that cause abnormal or excessive bleeding.<ref>Konkle BA, Josephson NC, Nakaya Fletcher S. Hemophilia A. 2000 Sep 21 [Updated 2014 Jun 5]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www-ncbi-nlm-nih-gov.laneproxy.stanford.edu/books/NBK1404/ </ref>


==Differentiating Hemophilia A from other Diseases==
==Differentiating Hemophilia A from other Diseases==
Line 26: Line 26:
! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
|-  
|-  
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dehydration
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint Bleeding
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lethargy
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gastrointestinal bleeding
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Musculoskeletal pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin Bruises
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Blood Pressure
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Edema
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Growth
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Proteinuria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Aminoaciduria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum Phosphate
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PTT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum [Na<sup>+</sup>]
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum [K<sup>+</sup>]
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Factor VIII
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Anion Gap
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Factor IX
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Serum PH
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fibrinogen
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine PH
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |U/A
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine [Ca<sup>2+</sup>]
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |S/E
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Fanconi syndrome|Fanconi Syndrome]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemophilia A
| style="background: #F5F5F5; padding: 5px; text-align: center;" |        '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |        '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |      '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |      '''<big>+</big>'''
Line 56: Line 56:
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" | <small>5.5</small>'''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |   '''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Osteomalacia]]/[[Rickets]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[RTA|Proximal RTA]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemophilia B
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
Line 74: Line 74:
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" | <small>5.5</small>'''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |High fractional [[Bicarbonate|HCO3<sup>-</sup>]] excretion
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[RTA|Distal RTA]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[von Willebrand disease]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
Line 92: Line 92:
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<small>5.5</small><big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |     '''<big>↑</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Kidney stone|Nephrplithiasis]]/
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
[[Osteomalacia]]/[[Rickets]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[RTA|RTA Type IV]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vitamin K deficiency
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
Line 111: Line 110:
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" | <small>5.5</small>'''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hypoaldosteronism|Hyporeninemic Hypoaldosteronism]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nephrotic syndrome|Nephrotic Syndrome]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Warfarin Toxicity
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>+</big>'''
Line 129: Line 128:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓↓/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓↓/</big>N'''
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N
! style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hyperlipidemia (patient information)|Hyperlipidemia]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Gitelman syndrome]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Platelets disorders
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
Line 147: Line 146:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    <big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    <big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<small>5.5</small><big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |       '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Often [[asymptomatic]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bartter's  syndrome]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Liver Failure
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>'''
Line 165: Line 164:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |  '''<big>↑/</big>N'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    <big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |    <big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<small>5.5</small><big>'''↑'''</big>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |       '''<big>↑</big>'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Kidney stone|Nephrplithiasis]]/[[Rickets]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |
|}
|}



Revision as of 04:48, 14 July 2018

Hemophilia A Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophilia A from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophilia A differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophilia A differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophilia A differential diagnosis

CDC on Hemophilia A differential diagnosis

Hemophilia A differential diagnosis in the news

Blogs on Hemophilia A differential diagnosis

Directions to Hospitals Treating Hemophilia A

Risk calculators and risk factors for Hemophilia A differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fahd Yunus, M.D. [2]

Overview

Hemophilia A must be differentiated from other diseases that cause abnormal or excessive bleeding.[1]

Differentiating Hemophilia A from other Diseases

The most important differential diagnosis is that of hemophilia B (also known as Christmas disease) or von Willebrand disease. The former is usually considered if factor VIII levels are normal in a person with a hemophilia phenotype. The latter is excluded on routine testing for that condition.

Differential Diagnosis

Other diseases which should be considered in the differential include:

Diseases Clinical manifestations Para-clinical findings Additional findings
Symptoms Physical examination
Lab Findings
Joint Bleeding Gastrointestinal bleeding Skin Bruises CBC PT PTT BT Factor VIII Factor IX Fibrinogen U/A S/E
Hemophilia A + + + ↓/N - + + ↓/N ↓/N N
Hemophilia B - -/+ -/+ N - ↓/N - - N N ↓/N N
von Willebrand disease - -/+ -/+ N - ↓↓/N - - N N ↓/N N
Vitamin K deficiency - -/+ -/+ N - N - - N ↓ ↓ ↑ ↑ N
Warfarin Toxicity -/+ + - ↑/N + + - N ↓/N N ↓↓/N N
Platelets disorders - + -/+ - N - - ↓/N ↑/N
Liver Failure -/+ -/+ - - - ↓/N ↑/N

References

  1. Konkle BA, Josephson NC, Nakaya Fletcher S. Hemophilia A. 2000 Sep 21 [Updated 2014 Jun 5]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www-ncbi-nlm-nih-gov.laneproxy.stanford.edu/books/NBK1404/

Template:WH Template:WS